News

Japan's bond yield surge hints at global market risks. See how it impacts U.S. Treasuries, the yen, and top investments like ...
Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year partnership with Sanofi , an innovative global healthcare company, and Regeneron , a ...
Fed officials say debt downgrade complicates inflation outlook, Nvidia CEO discusses China chip ban, JPMorgan’s investor day, ...
World shares experienced a rally following China's decision to cut key interest rates in response to economic challenges ...
Regeneron Pharmaceuticals is set to acquire 23andMe for $256 million following its bankruptcy filing due to declining demand ...
The US’s credit rating took a hit on Friday, after Moody’s downgraded the country’s AAA rating. And then yesterday, bond prices followed suit. Here to explain the significance of these market moves is ...
Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...
U.S. stocks finished near the unchanged mark on Monday with market sentiment weakened by the downgrade of the federal ...
The Moody’s announcement sent the yield on a 30-year Treasury bond to a high of 5.01% at one point on Monday. Bond yields ...
It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...
Regeneron to rescue 23andMe in a $256 million deal, raising major questions about DNA privacy, genetic data ownership, and ...